Literature DB >> 2151756

The relationship between suppression of acidity and gastric ulcer healing rates.

C W Howden1, R H Hunt.   

Abstract

We have investigated the relationship between the suppression of acidity by antisecretory drugs for the treatment of benign gastric ulcer and their corresponding ulcer-healing rates. For a variety of antisecretory drug regimens, there was a significant correlation between suppression of 24-h intragastric acidity and ulcer healing rates after 2, 4 and 8 weeks of treatment. There was a lesser degree of correlation between healing and suppression of nocturnal acidity and the association between suppression of acidity and gastric-ulcer healing rates was less marked than that previously described for duodenal ulcer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2151756     DOI: 10.1111/j.1365-2036.1990.tb00445.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

1.  Short-term treatment of gastric ulcer. A meta-analytical evaluation of blind trials.

Authors:  F Di Mario; G Battaglia; G Leandro; G Grasso; F Vianello; S Vigneri
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Acid suppression: how much is needed?

Authors:  D G Colin-Jones
Journal:  BMJ       Date:  1990-09-22

3.  Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.

Authors:  Ping-I Hsu; Deng-Chyang Wu; Feng-Woei Tsay; Jin-Shiung Cheng; Chun-Peng Liu; Kwok-Hung Lai; Wen-Chi Chen; Huay-Min Wang; Tzung-Jiun Tsai; Kuo-Wang Tsai; Sung-Shuo Kao
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

Review 4.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

5.  Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.

Authors:  Kae Sugawara; Shigeto Koizumi; Yohei Horikawa; Nobuya Mimori; Tsuyotoshi Tsuji; Hajime Ishii; Shusei Fujimori; Kengo Onochi; Hiroyuki Watanabe; Katsunori Iijima
Journal:  J Gastroenterol       Date:  2019-04-29       Impact factor: 7.527

Review 6.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  Acid peptic diseases: pharmacological approach to treatment.

Authors:  Alex Mejia; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2009-05       Impact factor: 5.045

Review 8.  Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.

Authors:  N J Bell; R H Hunt
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

Review 9.  Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.

Authors:  Julia Kirchheiner; Silke Glatt; Uwe Fuhr; Ulrich Klotz; Ingolf Meineke; Thomas Seufferlein; Jürgen Brockmöller
Journal:  Eur J Clin Pharmacol       Date:  2008-10-17       Impact factor: 2.953

10.  A randomized, double blinded, clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux disease.

Authors:  Jung Ho Park; Hyojin Park; Dong Ho Lee; In Kyung Sung
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.